
Immunoglobulins
Latest News
Advertisement
CME Content
Advertisement


The first report of long-term (3-year) stabilization of Alzheimer's disease symptoms with IVIG, including no decline on measures of cognition, memory, daily functioning and mood, was recently reported at the Alzheimer's Association International Conference 2012 in Vancouver.


This home delivery pharmacy focuses in intravenous immune globulin programs to improve care and outcomes for patients.

When patients have immunodeficiency conditions that require immunoglobulin therapy (IVIG), clinicians must consider carefully which IVIG product will have the fewest adverse effects and the highest level of efficacy.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Expands Approval of Ferric Maltol to Adolescents, Addressing a Critical Gap in Iron Deficiency Care
2
The ABCs of Vitamin D Supplements: Exploring Their Health Benefits and Proper Use
3
Occupational Factors Can Increase Risk of Long COVID
4
T-DXd Granted Breakthrough Therapy Designation in Post-Neoadjuvant HER2-Positive Early Breast Cancer
5

































































































































































































